Pharmaceutical giant Endo Pharmaceuticals Inc., and seven of its subsidiaries, will pay $39 million to settle a whistleblower lawsuit alleging the company manufactured and sold chewable fluoride multivitamins containing less than half the labeled dosage. Fluoride is critical to the dental health of children living in communities without fluoridated drinking water.

 
FCA | McCabe Rabin, Endo Pharmaceuticals